Table 1 Baseline study participant data
Characteristic, mean (SD) or as indicated | ||
|---|---|---|
|  | Trial Participants N = 10 | Participants with paired skin biopsies N = 5 |
Age | 49.6 (7.3) | 53.2 (4.34) |
dcSSc duration (y) | 4.46 (1.01) | 4.2 (0.84) |
Female, n (%) | 10 (100) | 5 (100) |
Race/Ethnicity, n (%) | ||
 White, non-Hispanic | 8 (80) | 5 (100) |
 Black or African American, non-Hispanic | 2 (20) | 0 (0) |
Positive Anti-Scl-70, n (%) | 2 (25) n = 8 | 1 (20) |
Positive Anti-RNA polymerase III, n (%) | 4 (50) n = 8 | 3 (60) |
Baseline FVC % predicted (L) | 85 (20) | 71 (25.9) |
Baseline DLCO % predicted (L) | 75 (14) | 66.8 (7.8) |
ILD on HRCT, n (%) | 1 (11.1) n = 9 | 1 (20) |
mRSS | 24.9 (6.79) | 24.4 (9.81) |